Lumida
/MRSN
⌘K
Mersana Therapeutics Inc

Mersana Therapeutics Inc

MRSN
$29.08USD+0.14%+0.04 today

MARKET CAP

145.4M

P/E (TTM)

FWD P/E

DAY RANGE

$29 – $30

52W RANGE

$5
$38
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$828,000$43,000$26.6M$36.9M$40.5M
YoY %-98.0%-94.8%+61716.3%+38.7%+9.9%
P / Sales
EV / Sales
Gross Profit, Adj.$828,000$43,000$26.6M$36.9M$40.5M
YoY %-98.0%-94.8%+61716.3%+38.7%+9.9%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-87.1M$-168.0M$-202.8M$-169.4M$-71.7M
YoY %-200.8%-92.9%-20.7%+16.5%+57.7%
Margin %-10519.3%-390704.7%-763.1%-459.7%-177.1%
EV / EBITDA
EBIT$-88.1M$-168.9M$-203.8M$-179.7M$-73.3M
YoY %-191.8%-91.6%-20.7%+11.8%+59.2%
Margin %-10641.3%-392693.0%-766.6%-487.5%-181.1%
EV / EBIT
Net Income$-88.0M$-170.1M$-204.2M$-171.7M$-69.2M
YoY %-212.1%-93.2%-20.1%+15.9%+59.7%
Net Margin-10633.5%-395488.4%-768.3%-465.8%-170.9%
EPS (GAAP)-$35.75-$60.25-$54.50-$37.00-$14.00
YoY %-120.0%-68.5%+9.5%+32.1%+62.2%